Adenosine Receptors in Modulation of Central Nervous System Disorders.

作者: Hira Choudhury , Dinesh K. Chellappan , Pallav Sengupta , Manisha Pandey , Bapi Gorain

DOI: 10.2174/1381612825666190712181955

关键词:

摘要: The ubiquitous signaling nucleoside molecule, adenosine is found in different cells of the human body to provide its numerous pharmacological role. associated actions endogenous are largely dependent on conformational change widely expressed heterodimeric G-protein-coupled A1, A2A, A2B, and A3 receptors (ARs). These well conserved surface specific cells, where potent neuromodulatory properties this bioactive molecule reflected by easy passage through rigid blood-brainbarrier, simultaneously act central nervous system (CNS). minimal concentration fluids (30-300 nM) adequate exert action CNS, whereas modulatory effect ARs consequence several neurodegenerative diseases. Modulatory concerning activation such CNS could be facilitated towards neuroprotective against disorders. Our aim herein discuss briefly pathophysiological roles modulation disorders, which focused identification potential drug targets recovering accompanying Researches with active components AR have been extended already reached bedside patients clinical research improvement Therefore, review consist recent findings literatures impact diverse disease pathways possible relevance neurodegeneration.

参考文章(263)
Ikwunga Wonodi, Hirekatur V. Gopinath, Judy Liu, Helene Adami, L. Elliot Hong, Robert Allen-Emerson, Robert P. McMahon, Gunvant K. Thaker, Dipyridamole monotherapy in schizophrenia Psychopharmacology. ,vol. 218, pp. 341- 345 ,(2011) , 10.1007/S00213-011-2315-3
Jiang-Fan Chen, Adenosine Receptor Control of Cognition in Normal and Disease International Review of Neurobiology. ,vol. 119, pp. 257- 307 ,(2014) , 10.1016/B978-0-12-801022-8.00012-X
Ted Abel, Peter V. Nguyen, Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Progress in Brain Research. ,vol. 169, pp. 97- 115 ,(2008) , 10.1016/S0079-6123(07)00006-4
Sergi Ferré, Jordi Bonaventura, Dardo Tomasi, Gemma Navarro, Estefanía Moreno, Antonio Cortés, Carme Lluís, Vicent Casadó, Nora D. Volkow, Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer Neuropharmacology. ,vol. 104, pp. 154- 160 ,(2016) , 10.1016/J.NEUROPHARM.2015.05.028
Gemma Navarro, Dasiel O. Borroto-Escuela, Kjell Fuxe, Rafael Franco, Purinergic signaling in Parkinson's disease. Relevance for treatment Neuropharmacology. ,vol. 104, pp. 161- 168 ,(2016) , 10.1016/J.NEUROPHARM.2015.07.024
Akinori Nishi, Gretchen L. Snyder, Paul Greengard, Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine The Journal of Neuroscience. ,vol. 17, pp. 8147- 8155 ,(1997) , 10.1523/JNEUROSCI.17-21-08147.1997
Lydia Giménez-Llort, Alberto Fernández-Teruel, Rosa Maria Escorihuela, Bertil B. Fredholm, Adolf Tobeña, Milos Pekny, Björn Johansson, Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate European Journal of Neuroscience. ,vol. 16, pp. 547- 550 ,(2002) , 10.1046/J.1460-9568.2002.02122.X
E. R. Dorsey, R. Constantinescu, J. P. Thompson, K. M. Biglan, R. G. Holloway, K. Kieburtz, F. J. Marshall, B. M. Ravina, G. Schifitto, A. Siderowf, C. M. Tanner, Projected number of people with parkinson disease in the most populous nations, 2005 through 2030 Neurology. ,vol. 68, pp. 384- 386 ,(2007) , 10.1212/01.WNL.0000247740.47667.03
Bertil B. Fredholm, Jiang-Fan Chen, Rodrigo A. Cunha, Per Svenningsson, Jean-Marie Vaugeois, Adenosine and Brain Function International Review of Neurobiology. ,vol. 63, pp. 191- 270 ,(2005) , 10.1016/S0074-7742(05)63007-3